Clinical trial
UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy…
NCT00345475 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00345475 |
|---|---|
| Title | UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry) |
| Official title | A Prospective Study Of Pregnancies Exposed to UCB Antiepileptic Drugs to Determine if There is a Potential Increase in the Risk of Major Birth Defects |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Birth Defects, Pregnancy Complications, Epilepsy, Seizures |
| Enrollment | 516 |
| Start date | Dec 1, 2004 |
| Primary completion | May 1, 2016 |
| Completion | May 1, 2016 |
| First posted | Jun 28, 2006 |
| Last update posted | Sep 2, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: